198 related articles for article (PubMed ID: 29481337)
1. Metformin for lung cancer prevention and improved survival: a novel approach.
Roos JF; Qudsi M; Samara A; Rahim MM; Al-Bayedh SA; Ahmed H
Eur J Cancer Prev; 2019 Jul; 28(4):311-315. PubMed ID: 29481337
[TBL] [Abstract][Full Text] [Related]
2. Metformin prevents tobacco carcinogen--induced lung tumorigenesis.
Memmott RM; Mercado JR; Maier CR; Kawabata S; Fox SD; Dennis PA
Cancer Prev Res (Phila); 2010 Sep; 3(9):1066-76. PubMed ID: 20810672
[TBL] [Abstract][Full Text] [Related]
3. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis.
Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X
J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122
[TBL] [Abstract][Full Text] [Related]
4. Metformin and Breast Cancer: Molecular Targets.
Faria J; Negalha G; Azevedo A; Martel F
J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
[TBL] [Abstract][Full Text] [Related]
5. Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner.
Tsai MJ; Yang CJ; Kung YT; Sheu CC; Shen YT; Chang PY; Huang MS; Chiu HC
Lung Cancer; 2014 Nov; 86(2):137-43. PubMed ID: 25267165
[TBL] [Abstract][Full Text] [Related]
6. Repurposing old drugs to chemoprevention: the case of metformin.
Heckman-Stoddard BM; Gandini S; Puntoni M; Dunn BK; DeCensi A; Szabo E
Semin Oncol; 2016 Feb; 43(1):123-133. PubMed ID: 26970131
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling.
Quinn BJ; Dallos M; Kitagawa H; Kunnumakkara AB; Memmott RM; Hollander MC; Gills JJ; Dennis PA
Cancer Prev Res (Phila); 2013 Aug; 6(8):801-10. PubMed ID: 23771523
[TBL] [Abstract][Full Text] [Related]
8. Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis.
Zhang ZJ; Bi Y; Li S; Zhang Q; Zhao G; Guo Y; Song Q
Am J Epidemiol; 2014 Jul; 180(1):11-4. PubMed ID: 24920786
[TBL] [Abstract][Full Text] [Related]
9. Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789
[TBL] [Abstract][Full Text] [Related]
10. Teaching an old drug new tricks: metformin as a targeted therapy for lung cancer.
Antonoff MB; D'Cunha J
Semin Thorac Cardiovasc Surg; 2010; 22(3):195-6. PubMed ID: 21167452
[TBL] [Abstract][Full Text] [Related]
11. Metformin Use and Lung Cancer Risk--Letter.
Mutoh M; Ishikawa H
Cancer Prev Res (Phila); 2015 Aug; 8(8):760. PubMed ID: 25990086
[No Abstract] [Full Text] [Related]
12. Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells.
Lv Y; Tian N; Wang J; Yang M; Kong L
J Pharm Biomed Anal; 2018 Jul; 156():153-162. PubMed ID: 29705631
[TBL] [Abstract][Full Text] [Related]
13. Anti-diabetic drug metformin: challenges and perspectives for cancer therapy.
Snima KS; Pillai P; Cherian AM; Nair SV; Lakshmanan VK
Curr Cancer Drug Targets; 2014; 14(8):727-36. PubMed ID: 25329671
[TBL] [Abstract][Full Text] [Related]
14. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
[TBL] [Abstract][Full Text] [Related]
15. Re: "reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis".
Hense HW; Geier AS
Am J Epidemiol; 2014 Dec; 180(11):1130-1. PubMed ID: 25414205
[No Abstract] [Full Text] [Related]
16. Re.: "Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis".
Schmedt N; Azoulay L; Hense S
Am J Epidemiol; 2014 Dec; 180(12):1216-7. PubMed ID: 25395024
[No Abstract] [Full Text] [Related]
17. Metformin: a metabolic modulator.
Pietrocola F; Kroemer G
Oncotarget; 2017 Feb; 8(6):9017-9020. PubMed ID: 28122334
[TBL] [Abstract][Full Text] [Related]
18. Comment on: Smiechowski et al. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care 2013;36:124-129.
Lai SW; Liao KF
Diabetes Care; 2013 Mar; 36(3):e40. PubMed ID: 23431102
[No Abstract] [Full Text] [Related]
19. Response to comment on: Smiechowski et al. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care 2013;36:124-129.
Suissa S; Azoulay L
Diabetes Care; 2013 Mar; 36(3):e41. PubMed ID: 23431103
[No Abstract] [Full Text] [Related]
20. Metformin and ovarian cancer survival: is there a rational warrant for belief?
Mormile R
Arch Gynecol Obstet; 2019 Oct; 300(4):797-798. PubMed ID: 31346700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
